Editas Medicine, Inc. (EDIT) SEC filings
EDITNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3047% above fair value
$2.38−0.13 (-4.99%)
Close on Nov 11, 2026Market cap $365.52MP/E –Yield –
SEC filings
40 of Editas Medicine's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 9, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 9, 2026 | Nov 9, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 8, 2026 | Oct 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 18, 2026 | SEC EDGAR |
| Current report | 8-K | May 26, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 26, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 25, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 28, 2026 | Apr 28, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2026 | Apr 7, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2025 | Oct 9, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 29, 2025 | Jun 2, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 15, 2025 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2025 | Mar 20, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2024 | Dec 17, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 12, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 6, 2024 | Dec 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 4, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2024 | Nov 4, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2024 | Oct 22, 2024 | SEC EDGAR |
See a number that looks wrong?